KRAS and familial pancreatic carcinoma: The significance of JNK activation in pancreatic cancer biology remained unclear, but we have only recently demonstrated that JNK activation by KRas, which is mutationally activated in the majority of pancreatic cancers, plays a key role in the maintenance of self-renewal and tumor-initiating capacity of pancreatic CSCs [15].